Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I R Judson

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Cancer Research|October 1, 1989
Phase I trial and pharmacokinetics of trimelamol (N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine)I R Judson, A H Calvert, C J Rutty, et al.
Anticancer Research|July 1, 1996
The activity of N-(hydroxymethyl) melamines in fresh human ovarian tumour cells and xenograftsH M Coley, M Jarman, M Jones, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717)A H Calvert, D R Newell, A L Jackman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Phase I trial of ZD1694, a new folate-based thymidylate synthase inhibitor, in patients with solid tumorsS J Clarke, J Hanwell, M de Boer, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2004
Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumoursP M J McSheehy, R E Port, L M Rodrigues, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma GroupL Svancárová, J Y Blay, I R Judson, et al.
British Journal of Cancer|June 4, 2014
Dichloroacetate induces autophagy in colorectal cancer cells and tumoursG Lin, D K Hill, G Andrejeva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2021
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)<sup>☆</sup>P G Casali, A Le Cesne, A P Velasco, et al.
The British Journal of Radiology|October 1, 2004
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trialsM O Leach, K M Brindle, J L Evelhoch, et al.
British Journal of Cancer|May 5, 2005
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendationsM O Leach, K M Brindle, J L Evelhoch, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Cancer Research|October 1, 1989
Phase I trial and pharmacokinetics of trimelamol (N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine)I R Judson, A H Calvert, C J Rutty, et al.
Anticancer Research|July 1, 1996
The activity of N-(hydroxymethyl) melamines in fresh human ovarian tumour cells and xenograftsH M Coley, M Jarman, M Jones, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717)A H Calvert, D R Newell, A L Jackman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Phase I trial of ZD1694, a new folate-based thymidylate synthase inhibitor, in patients with solid tumorsS J Clarke, J Hanwell, M de Boer, et al.
Cancer Chemotherapy and Pharmacology|December 14, 2004
Investigations in vivo of the effects of carbogen breathing on 5-fluorouracil pharmacokinetics and physiology of solid rodent tumoursP M J McSheehy, R E Port, L M Rodrigues, et al.
European Journal of Cancer (Oxford, England : 1990)|March 2, 2002
Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma GroupL Svancárová, J Y Blay, I R Judson, et al.
British Journal of Cancer|June 4, 2014
Dichloroacetate induces autophagy in colorectal cancer cells and tumoursG Lin, D K Hill, G Andrejeva, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 22, 2021
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)<sup>☆</sup>P G Casali, A Le Cesne, A P Velasco, et al.
The British Journal of Radiology|October 1, 2004
Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trialsM O Leach, K M Brindle, J L Evelhoch, et al.
British Journal of Cancer|May 5, 2005
The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendationsM O Leach, K M Brindle, J L Evelhoch, et al.
Pageof 7